IRL-201805
N/A
Report date: 2024/11/05 16:42:59
Base Information
Drug NameIRL-201805
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKing'S College LondonPeptinnovate
China Registration ClassN/A
Develop Information
Active CompaniesPeptinnovateKing'S College London
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A